only 5-10% NPAT hit by my numbers...60% off today...a little *exaggerated* impact is $5m to EBIT only, but they had some positives out of the DEECD, so net impact will be only a few million...and they can do acquisitions to compensate
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market